These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 14624207)

  • 1. The effect of antipsychotics on plasma lipids.
    Sramek JJ; Cutler NR; Shiovitz T
    J Clin Psychopharmacol; 2003 Dec; 23(6):679-80. PubMed ID: 14624207
    [No Abstract]   [Full Text] [Related]  

  • 2. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of atypical antipsychotics for the management of schizophrenia.
    Sprague DA; Loewen PS; Raymond CB
    Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
    Nosè M; Cipriani A; Biancosino B; Grassi L; Barbui C
    Int Clin Psychopharmacol; 2006 Nov; 21(6):345-53. PubMed ID: 17012981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of schizophrenia patients: comparing new-generation antipsychotics to each other.
    Fleischhacker WW; Widschwendter CG
    Curr Opin Psychiatry; 2006 Mar; 19(2):128-34. PubMed ID: 16612191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
    Bushe C; Paton C
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):76-83. PubMed ID: 16280340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer antipsychotics similar to older agents.
    J Fam Pract; 2005 Dec; 54(12):1026. PubMed ID: 16370079
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms.
    Mercer D; Douglass AB; Links PS
    J Pers Disord; 2009 Apr; 23(2):156-74. PubMed ID: 19379093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of atypical antipsychotics in the treatment of autistic disorder.
    Stachnik JM; Nunn-Thompson C
    Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic mapping of atypical antipsychotic effects in schizophrenia.
    Kaddurah-Daouk R; McEvoy J; Baillie RA; Lee D; Yao JK; Doraiswamy PM; Krishnan KR
    Mol Psychiatry; 2007 Oct; 12(10):934-45. PubMed ID: 17440431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia.
    Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E
    Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical antipsychotics in the treatment of mood disorders.
    Jarema M
    Curr Opin Psychiatry; 2007 Jan; 20(1):23-9. PubMed ID: 17143078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):371-2. PubMed ID: 16382376
    [No Abstract]   [Full Text] [Related]  

  • 16. In the aftermath of CATIE: how should administrators value atypical antipsychotic medications?
    Luchins DJ
    Adm Policy Ment Health; 2006 Sep; 33(5):541-3. PubMed ID: 16688482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of atypical antipsychotics on plasma lipid pools, cholesterol, and triglycerides.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):80-4. PubMed ID: 19667656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
    Tandon R; Carpenter WT; Davis JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):977-8; author reply 979-80. PubMed ID: 17679642
    [No Abstract]   [Full Text] [Related]  

  • 19. An evaluation of monitoring practices in patients on second generation antipsychotics.
    Nguyen D; Brakoulias V; Boyce P
    Australas Psychiatry; 2009 Aug; 17(4):295-9. PubMed ID: 19585292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.